Kaiser Permanente Northern California’s Division of Research has received a $5 million grant from the American Heart Association to study how AI can improve screening and treatment for cardiovascular disease.
The funding, announced in a July 29 news release, will support a multi-center clinical trial led by David Ouyang, MD, a research scientist at the Division of Research and a cardiologist with The Permanente Medical Group. The trial will explore how AI can enhance the effectiveness of echocardiograms, or heart ultrasounds, in cardiac care.
The study will be conducted across four sites:
- Kaiser Permanente Northern California, with Andrew Ambrosy, MD; Ankeet Bhatt, MD; and Alan Go, MD.
- Stanford Health Center, with Alex Sandhu, MD, and Jason Hom, MD.
- Los Angeles-based Cedars-Sinai Smidt Heart Institute, with Alan Kwan, MD, and Susan Cheng, MD.
- Somerville, Mass.-based Mass General Brigham, with Long Nguyen, MD; Tracey Simon, MD; and Emily Lau, MD.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.